By Elias F. Darido, MD, FACS
Foregut & GERD Surgeon | Houston Weight Loss Surgery Center & Houston Heartburn and Reflux Center
Fellowship-trained in foregut surgery, University of North Carolina at Chapel Hill
20+ Years in Practice | 1,000+ Sleeve Gastrectomy Procedures | 1,000+ Hiatal Hernia and Anti-Reflux Procedures
Published: January 2020 | Last Reviewed: September 2026
Laura from Houston sent us this question:
“Hello. I have a BMI of 32.6 and high blood pressure, which has landed me in the ER twice this year. Additionally, I was diagnosed with Barrett’s esophagus over a decade ago and have been treated with PPIs and monitored regularly. Although I do not meet the criteria for weight loss surgery for insurance, I am interested in off-label (self-pay) surgery for the sake of my health. I have tried many times to lose weight without success. Gastric bypass has been recommended to me in lieu of the sleeve, but that seems quite extreme for my BMI. I am very interested in your thoughts on this, given your knowledge of reflux and bariatric surgery. Both of my grandmothers died of strokes early in life, and I am very concerned about my health as I near 50.”
Dear Laura,
Thank you for sharing your health concerns and a medical problem that, honestly, still doesn’t have a clean, universally agreed-upon answer. Let me update you on where things stand.
BMI Criteria Are Outdated, and Your Risk Profile Matters More
BMI cutoffs for weight loss surgery were set decades ago and haven’t kept pace with what we now know about metabolic risk. For someone with a BMI between 30 and 35 and two significant comorbidities like high blood pressure and Barrett’s esophagus, who has failed to achieve durable weight loss on their own, weight loss surgery is medically indicated regardless of what an insurance formula says.
I also agree with you that gastric bypass, while effective and safe, is a more aggressive operation than sleeve gastrectomy, particularly for someone at a lower BMI. Sleeve gastrectomy is an equally effective weight loss procedure, is less invasive, and doesn’t carry bypass’s long-term risks of marginal ulceration or internal hernia. So the real question isn’t sleeve versus bypass in general. It’s whether Barrett’s esophagus specifically should take sleeve off the table for you.
What the Evidence Actually Says About Barrett’s and Sleeve Gastrectomy
The American Gastroenterological Association (AGA) classifies established Barrett’s esophagus as a relative, not absolute, contraindication to sleeve gastrectomy, in the same category as refractory GERD. That’s an important distinction, and it’s one that’s genuinely debated among bariatric surgeons.
Why many surgeons still avoid sleeve in Barrett’s patients:
Sleeve gastrectomy is thought to be a refluxogenic operation, meaning it can cause or worsen acid reflux. A systematic review of 46 studies covering 10,718 sleeve gastrectomy patients found a 23% rate of new-onset reflux, a 28% long-term prevalence of esophagitis, an 8% prevalence of Barrett’s esophagus, and roughly 4% of patients requiring conversion to gastric bypass for severe reflux. A more recent meta-analysis focused specifically on long-term follow-up found new Barrett’s develops in about 5.6% of sleeve patients overall, with the risk rising meaningfully after 10 years. This is the data that leads many surgeons to prefer Roux-en-Y gastric bypass for patients with confirmed Barrett’s: bypass diverts bile away from the esophagus, reduces acid production in the gastric pouch, and is associated with regression or resolution of existing Barrett’s in a way sleeve is not.
Why it hasn’t become an absolute contraindication:
At the same time, the association between sleeve and Barrett’s turns out to be weaker than the reflux data alone would predict. Several series report post-sleeve Barrett’s rates (roughly 2–6%) that are comparable to what you’d see in the general obese or GERD population (not dramatically higher). A large matched cohort of 16,724 patients actually found lower rates of Barrett’s after sleeve than after bypass (0.7% vs. 1.1%), with no difference in reflux esophagitis between the two operations. Large population-level studies have also found that esophageal cancer incidence after sleeve is not elevated compared to bypass or to non-surgical obese controls. Small series of patients with non-dysplastic Barrett’s who underwent sleeve have shown no short-term progression.
My Own Approach: Why the Details of the Operation Matter
At Houston Weight Loss Surgery Center, my own sleeve gastrectomy outcomes have looked different from the pooled literature, and I believe the reason is technical. I have found that a properly performed sleeve gastrectomy, combined with a properly performed hiatal hernia repair, resolves acid reflux rather than causing it. The gastric sleeve lumen must be uniform, with no narrowing or twisting. The herniated stomach and distal esophagus must be fully reduced into the abdominal cavity, restoring normal anatomy. The gastric antrum must be preserved to promote proper gastric emptying. Every one of my sleeve gastrectomy patients with documented preoperative acid reflux has reported complete symptom resolution immediately after surgery, and before any significant weight loss occurred.
Most of the studies driving the “sleeve worsens reflux” narrative don’t specify whether hiatal hernias were present or properly repaired, or whether the sleeve lumen was free of narrowing. Patients who had sleeve gastrectomy elsewhere and later came to me for reflux evaluation have, without exception, been found to have hiatal hernias and sleeve lumen narrowing. I don’t yet have personal outcomes data on Barrett’s esophagus specifically regressing after sleeve at our center, and I want to be upfront about that. But if reflux is genuinely eliminated by proper anatomic reconstruction, it’s reasonable to expect Barrett’s mucosa to stabilize or improve rather than progress; this assumption still needs a dedicated study.
Back to Your Question, Laura
Would I offer sleeve gastrectomy to a patient with Barrett’s esophagus? The AGA’s own classification supports that this is not an automatic disqualification, and I don’t believe there’s a single correct answer here. The general consensus among bariatric surgeons still leans toward gastric bypass for patients with confirmed Barrett’s, and that remains the more conservative, better-studied path. My own view is more optimistic about sleeve in carefully selected patients: non-dysplastic Barrett’s, a properly performed hiatal hernia repair, a uniform sleeve lumen, and a commitment to structured long-term endoscopic surveillance afterward. Should reflux worsen after sleeve gastrectomy, something I have not yet seen in my own patients under these conditions, conversion from sleeve to bypass remains a straightforward option.
Key Clinical Points
- The AGA classifies Barrett’s esophagus as a relative, not absolute, contraindication to sleeve gastrectomy
- Pooled data show real reflux risk after sleeve (23% new-onset reflux, 8% Barrett’s in one large review), but newer long-term data show Barrett’s rates after sleeve that are comparable to, or in some cohorts lower than, rates after gastric bypass
- A properly performed sleeve gastrectomy (uniform lumen, full hiatal hernia reduction, and antrum preservation) has resolved reflux in all of my patients with documented preoperative GERD, prior to any significant weight loss
A Note for Patients Considering This Decision
If you’re weighing sleeve gastrectomy against gastric bypass and have a history of Barrett’s esophagus or chronic reflux, this isn’t a decision to make from a BMI chart or a generic recommendation. You deserve a comprehensive evaluation of your anatomy, your hiatal hernia (if you have one), and your endoscopic findings. I’d encourage you to reach out to Houston Weight Loss Surgery Center or Houston Heartburn and Reflux Center for that evaluation. A proper workup, done by someone who treats both reflux and obesity as connected problems, can make all the difference in choosing the right operation.
Elias F. Darido, MD, FACS
Houston Weight Loss Surgery Center | Houston Heartburn and Reflux Center